All Stories

  1. What is novel in the clinical management of pemphigus

    Article • Expert Review of Clinical Pharmacology, September 2019, Taylor & Francis

    Dedee Murrell

  2. Prevalence and pathogenesis of osteopenia and osteoporosis in epidermolysis bullosa: An evidence-based review

    Article • Experimental Dermatology, October 2018, Wiley

    Dedee Murrell

  3. Is the Oral Disease Severity Score going to be useful for dermatologists when assessing pemphigus?

    Article • British Journal of Dermatology, October 2018, Wiley

    Dedee Murrell

  4. The effect of autoimmune blistering diseases on work productivity

    Article • Journal of the European Academy of Dermatology and Venereology, May 2018, Wiley

    Dedee Murrell

  5. International Bullous Diseases Group: consensus on diagnostic criteria for epidermolysis bullosa acquisita

    Article • British Journal of Dermatology, May 2018, Wiley

    Dedee Murrell, Professor Branka Marinovic, Snejina Vassileva

  6. Use of systemic corticosteroids for atopic dermatitis: International Eczema Council consensus statement

    Article • British Journal of Dermatology, January 2018, Wiley

    Dedee Murrell, Phyllis Spuls

  7. Rituximab and short-course prednisone as the new gold standard for new-onset pemphigus vulgaris and pemphigus foliaceus

    Article • British Journal of Dermatology, November 2017, Wiley

    Dedee Murrell

  8. Digenic inheritance in epidermolysis bullosa simplex involving two novel mutations in KRT5 and KRT14

    Article • British Journal of Dermatology, June 2017, Wiley

    Dedee Murrell, Emma Kim

  9. Multiple sclerosis is the neurological disorder most highly associated with bullous pemphigoid

    Article • British Journal of Dermatology, June 2017, Wiley

    Dedee Murrell

  10. 2% Crisaborole topical ointment for the treatment of mild-to-moderate atopic dermatitis

    Article • Expert Review of Clinical Immunology, April 2017, Taylor & Francis

    Dedee Murrell

  11. The Epidermolysis Bullosa Disease Activity and Scarring Index (EBDASI): grading disease severity and assessing responsiveness to clinical change in epidermolysis bullosa

    Article • Journal of the European Academy of Dermatology and Venereology, October 2016, Wiley

    Dedee Murrell

  12. What is the true mortality from pemphigus?

    Article • British Journal of Dermatology, June 2016, Wiley

    Dedee Murrell

  13. Cover image: Unpeeling the layers of harlequin ichthyosis

    Article • British Journal of Dermatology, May 2016, Wiley

    Dedee Murrell

  14. Neonatal Autoimmune Blistering Disease: A Systematic Review

    Article • Pediatric Dermatology, April 2016, Wiley

    Dedee Murrell

  15. The distribution of epidermolysis bullosa in Australia with a focus on rural and remote areas

    Article • Australasian Journal of Dermatology, February 2016, Wiley

    Dedee Murrell

  16. Saggy skin as a presenting sign of angioimmunoblastic T-cell lymphoma

    Article • Clinical and Experimental Dermatology, December 2015, Wiley

    Dedee Murrell

  17. Burden of disease scoring in epidermolysis bullosa

    Article • British Journal of Dermatology, December 2015, Wiley

    Dedee Murrell

  18. Advances in understanding and managing bullous pemphigoid

    Article • F1000Research, November 2015, Faculty of 1000, Ltd.

    Dedee Murrell

  19. A review of case-control studies on the risk factors for the development of autoimmune blistering diseases

    Article • Journal of the European Academy of Dermatology and Venereology, October 2015, Wiley

    Dedee Murrell

  20. Fifty shades of yellow: a review of the xanthodermatoses

    Article • International Journal of Dermatology, July 2015, Wiley

    Dr John W Frew, Dedee Murrell, Dr Richard M Haber

  21. A pilot comparison study of four clinician‐rated atopic dermatitis severity scales

    Article • British Journal of Dermatology, July 2015, Wiley

    Dedee Murrell

  22. Outcome measures for autoimmune blistering diseases

    Article • The Journal of Dermatology, January 2015, Wiley

    Dedee Murrell

  23. Screening for infections prior to initiating immunosuppressive treatment for patients with autoimmune blistering diseases

    Article • British Journal of Dermatology, December 2014, Wiley

    Dedee Murrell

  24. Diffuse melanosis cutis in the setting of BRAFV600Emetastatic melanoma

    Article • International Journal of Dermatology, September 2014, Wiley

    Dedee Murrell

  25. Dermatology training and practice in Australia

    Article • International Journal of Dermatology, September 2014, Wiley

    Dedee Murrell